Comparative efficacy of an optimal exam between ultrasound versus abbreviated MRI for HCC screening in NAFLD cirrhosis: A prospective study
Alimentary Pharmacology & Therapeutics2022Vol. 55(7), pp. 820–827
Citations Over TimeTop 10% of 2022 papers
Daniel Q. Huang, Kathryn J. Fowler, Joy Liau, Guilherme Moura Cunha, Ashley L. Louie, Julie Y. An, Ricki Bettencourt, Jinho Jung, Zachary Gitto, Christie Hernandez, Scarlett Lopez, Hersh Gupta, Claude B. Sirlin, Robert M. Marks, Rohit Loomba
Abstract
More than one-third of participants with NAFLD cirrhosis had severe visualisation limitations on US for HCC screening, compared with one-sixth on AMRI. US adequacy should be reported in all clinical studies and when suboptimal then AMRI may be considered for HCC screening.
Related Papers
- → Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer?(2018)22 cited
- Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.(2003)
- Application of Diffusion Weighted Imaging in Liver Cirrhosis and Hepatocellular Carcinoma at 3.0 T Magnetic Resonance(2008)
- [A clinical study of serum erythropoietin concentrations in patients with liver cirrhosis and hepatocellular carcinomas].(1990)
- → Hepatocellular Carcinoma at Initial Diagnosis of Cirrhosis(2023)